Handbook Of Pharmaceutical Excipients Edition 9 Pdf May 2026

This is a reference. Use the index first. Look for the excipient name, then go directly to the “Incompatibilities” and “Safety” sections. The “Pharmacopeial Specifications” section is vital for regulatory filings.

Given the pace of innovation in gene therapy, continuous manufacturing, and 3D-printed drugs, the industry expects Edition 10 around 2026–2027. Key anticipated additions include: handbook of pharmaceutical excipients edition 9 pdf

Until then, the 9th Edition remains the definitive source. This is a reference

With the rise of mRNA vaccines and gene therapies, Edition 9 expands coverage on excipients used in lipid nanoparticles (LNPs) and lyophilized biologics—areas untouched in prior editions. Until then, the 9th Edition remains the definitive source

The handbook is not a substitute for the USP-NF or Ph. Eur. It tells you what an excipient does; the pharmacopeia tells you how to test its purity. Use both.

| Excipient | Main use | Typical conc. | Key caution | |-----------|----------|---------------|--------------| | Lactose monohydrate | Filler (DC) | 30–80% | Maillard reaction with amines | | Crospovidone | Superdisintegrant | 2–5% | Swelling capacity reduced above 50% RH | | Magnesium stearate | Lubricant | 0.25–2.0% | Overmixing → poor tablet hardness | | HPMC (hypromellose) | Sustained release | 10–50% | Hydration rate depends on viscosity grade |